Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma-Reference-Cited by-同舟云学术

Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma

Published:2012-04-04 Issue:6 Volume:88 Page:497-503
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

El-Cheikh Jean,Crocchiolo Roberto,Boher Jean-Marie,Furst Sabine,Stoppa Anne-Marie,Ladaique Patrick,Faucher Catherine,Calmels Boris,Castagna Luca,Lemarie Claude,De Colella Jean-Marc Schiano,Coso Diane,Bouabdallah Reda,Chabannon Christian,Blaise Didier

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2012.01777.x/fullpdf

Reference26 articles.

1. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study;Kumar;Leukemia,2011

2. Hematopoietic stem cell transplantation for multiple myeloma beyond 2010;Blade;Blood,2010

3. International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma;Lokhorst;J Clin Oncol,2010

5. Unrelated stem cell transplantation for patients with multiple myeloma;Kroger;Curr Opin Hematol,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017;Cancer Cell International;2018-04-23

2. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features;Biology of Blood and Marrow Transplantation;2016-11

3. When to recommend allogeneic transplant in multiple myeloma;Leukemia & Lymphoma;2015-06-18

4. Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic;Clinical Lymphoma Myeloma and Leukemia;2015-06

5. The Graft-Versus-Myeloma Effect: Chronic Graft-Versus-Host Disease but Not Acute Graft-Versus-Host Disease Prolongs Survival in Patients with Multiple Myeloma Receiving Allogeneic Transplantation;Biology of Blood and Marrow Transplantation;2014-08